Outcome of palliative embolization of bone metastases in differentiated thyroid carcinoma

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 7, 2003, Pages 3184-3189

  Eustatia Rutten, C F A ^a   Romijn, J A ^a   Guijt, M J ^a   Vielvoye, G J ^a   Van Den Berg, R ^a   Corssmit, E P M ^a   Pereira, A M ^a   Smit, J W A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BONE METASTASIS; CANCER PALLIATIVE THERAPY; CELL DIFFERENTIATION; DISEASE COURSE; DISEASE DURATION; EVALUATION; FEMALE; FOLLOW UP; HUMAN; LAMINECTOMY; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIOIODINATION; SYMPTOMATOLOGY; THYROID CARCINOMA; TREATMENT OUTCOME;

ADENOCARCINOMA, FOLLICULAR; ADULT; AGED; BONE NEOPLASMS; CELL DIFFERENTIATION; EMBOLIZATION, THERAPEUTIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 0038298276     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030231     Document Type: Article

References (14)

1. Hundahl SA, Fleming ID, Fremgen AM, Menck HR 1998 A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 83:2638-2648
2. Mazzaferri EL, Kloos RT 2001 Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86:1447-1463
3. Schaap J, Eustatia-Rutten CF, Stokkel M, Links TP, Diamant M, van der Velde EA, Romijn JA, Smit JW 2002 Does radioiodine therapy have disadvantageous effects in non-iodine accumulating differentiated thyroid carcinoma? Clin Endocrinol (Oxf) 57:117-124
4. Samaan NA, Schultz PN, Haynie TP, Ordonez NG 1985 Pulmonary metastasis of differentiated thyroid carcinoma: treatment results in 101 patients. J Clin Endocrinol Metab 60:376-380
5. Ruegemer JJ, Hay ID, Bergstralh EJ, Ryan JJ, Offord KP, Gorman CA 1988 Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab 67:501-508
6. Pacini F, Cetani F, Miccoli P, Mancusi F, Ceccarelli C, Lippi F, Martino E, Pinchera A 1994 Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine. World J Surg 18:600-604
7. Schlumberger M, Challeton C, De Vathaire F, Travagli JP, Gardet P, Lumbroso JD, Francese C, Fontaine F, Ricard M, Parmentier C 1996 Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 37:598-605
8. Marcocci C, Pacini F, Elisei R, Schipani E, Ceccarelli C, Miccoli P, Arganini M, Pinchera A 1989 Clinical and biologic behavior of bone metastases from differentiated thyroid carcinoma. Surgery 106:960-966
9. Haugen BR 1999 Management of the patient with progressive radioiodine non-responsive disease. Semin Surg Oncol 16:34-41
10. Guibaud L, Herbreteau D, Dubois J, Stempfle N, Berard J, Pracros JP, Merland JJ 1998 Aneurysmal bone cysts: percutaneous embolization with an alcoholic solution of zein - series of 18 cases. Radiology 208:369-373
11. Gold RE, Grace DM 1975 Gelfoam embolization of the left gastric artery for bleeding ulcer: experimental considerations. Radiology 116:575-580
12. Sun S, Lang EV 1998 Bone metastases from renal cell carcinoma: preoperative embolization. J Vasc Interv Radiol 9:263-269
13. Smit JW, Vielvoye GJ, Goslings BM 2000 Embolization for vertebral metastases of follicular thyroid carcinoma. J Clin Endocrinol Metab 85:989-994
14. Rockwell S 1997 Oxygen delivery: implications for the biology and therapy of solid tumors. Oncol Res 9:383-390